J2 Capital Management Inc Makes New $294,000 Investment in Colgate-Palmolive (NYSE:CL)

J2 Capital Management Inc acquired a new stake in Colgate-Palmolive (NYSE:CL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 3,231 shares of the company's stock, valued at approximately $294,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Reston Wealth Management LLC bought a new stake in Colgate-Palmolive in the 3rd quarter valued at $42,000. Capital Performance Advisors LLP acquired a new position in shares of Colgate-Palmolive in the third quarter valued at $53,000. Prospera Private Wealth LLC bought a new position in shares of Colgate-Palmolive in the third quarter valued at about $64,000. True Wealth Design LLC lifted its stake in shares of Colgate-Palmolive by 1,460.9% during the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company's stock worth $75,000 after buying an additional 672 shares during the last quarter. Finally, Continuum Advisory LLC grew its stake in Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company's stock valued at $79,000 after buying an additional 368 shares during the last quarter. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

NYSE CL traded up $0.23 during trading on Friday, hitting $88.79. 5,149,874 shares of the company's stock were exchanged, compared to its average volume of 3,679,883. The stock's 50 day moving average price is $92.20 and its two-hundred day moving average price is $97.75. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The company has a market cap of $72.55 billion, a PE ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.25%. Colgate-Palmolive's dividend payout ratio is currently 57.31%.

Insiders Place Their Bets

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.34% of the company's stock.

Analyst Ratings Changes

CL has been the subject of a number of research analyst reports. Piper Sandler reduced their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a report on Monday, January 6th. Stifel Nicolaus reduced their price target on Colgate-Palmolive from $101.00 to $95.00 and set a "hold" rating for the company in a research note on Friday. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research report on Tuesday, January 7th. StockNews.com cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Thursday, January 9th. Finally, UBS Group lowered their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a "buy" rating on the stock in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive presently has a consensus rating of "Hold" and a consensus price target of $101.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.